Combined IL-12 Plasmid and Recombinant SjGST Enhance the Protective and Anti-pathology Effect of SjGST DNA Vaccine Against Schistosoma japonicum.

• Päätekijät: Po-Ching Cheng (Tekijä), Ching-Nan Lin (Tekijä), Shih-Yi Peng (Tekijä), Tsung-Fu Kang (Tekijä), Kin-Mu Lee (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Public Library of Science (PLoS), 2016-02-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Schistosomiasis is listed as one of most important tropical diseases and more than 200 million people are estimated to be infected. Development of a vaccine is thought to be the most effective way to control this disease. Recombinant 26-kDa glutathione S-transferase (rSjGST) has previously been repo...